Portrait of Cooper, Jim

Cooper, Jim

U.S. Representative TN-5 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
8
Buys / sells
25% / 75%
Last trade
Dec 21, 2016
Last filing
Jan 4, 2017

Latest disclosed trades

Latest 8 of 8
Ticker Type Traded
— Lot on East Holland st. F ILINg Sell Dec 21, 2016
— Park Center Partnership I F ILIN Buy Dec 13, 2016
— Park Center Partnership II F ILI Buy Dec 13, 2016
HBHC Sell Dec 7, 2016
— HgH Equity, LLC F ILINg S TaTuS Sell Sep 30, 2016
IBM Sell Jul 27, 2015
— CLP Healthcare service Inc. (Hos Sell Dec 22, 2014
SEM Sell Aug 6, 2014

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Cooper, Jim stock trade activity

FilingIQ has indexed 8 congressional stock trade disclosures for Cooper, Jim. The most recent disclosed transaction is dated Dec 21, 2016.

Across the full history, 2 purchases and 6 sales have been disclosed under the STOCK Act.

Top tickers traded by Cooper, Jim

Frequently asked

How many stock trades has Cooper, Jim disclosed?
FilingIQ tracks 8 Periodic Transaction Report disclosures for Cooper, Jim, with the most recent dated Dec 21, 2016. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Cooper, Jim a net buyer or net seller?
Across the disclosed trade history, 2 (25%) were purchases and 6 (75%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Cooper, Jim come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.